Lemaitre Vascular (LMAT) Tops Q4 EPS by 2c, provides guidance

Lemaitre Vascular (NASDAQ: LMAT) reported Q4 EPS of $0.68, $0.02 better than the analyst estimate of $0.66. Revenue for the quarter came in at $64.45 million versus the consensus estimate of $62.98 million.

GUIDANCE:

Lemaitre Vascular sees Q1 2026 revenue of $65.6-67.6 million, versus the consensus of $65.85 million.

Lemaitre Vascular sees FY2026 revenue of $276-284 million, versus the consensus of $270.5 million.

For earnings history and earnings-related data on Lemaitre Vascular (LMAT) click here.

You May Also Be Interested In

• Samsara Inc (IOT) call put ratio 4.5 calls to 1 put with a focus on September 4 weekly calls into quarter results
• Victoria's Secret & Co. (VSXY) Tops Q2 EPS by 20c ; Offers Guidance
• BRP Inc. (DOO) Reports Q2 Loss of Cd$0.18